Also, image-guided tPA administration in wake-up AIS patients, for up to 4.5 h from stroke symptom recognition, has received only moderate recommendation (class IIa), indicating conflicting evidence and/or a divergence of opinion about its efficacy, thus demanding more work in the area. Here, PLAT is linked to androgen insensitivity syndrome.